-
Cardiovascular Round Table - Industry Partners
The Cardiovascular Round Table comprises 20 industry partners from across the pharmaceuticals, devices and equipment sectors. Abbott Amgen AstraZeneca Bayer Boehringer-Ingelheim Bristol-Myers Squibb ...
Wednesday, October 10th 2018
-
RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation procedures
John Camm is Professor of Clinical Cardiology at St Georges University of London. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac ...
By Camm, A John Monday, October 1st 2018
-
Have you tried the all-new ESC 365?
ESC Congress 365 is now ESC 365. This all-new platform includes resources from ESC Congress and ESC subspecialty congresses. It features an enhanced, easy-to-use search function so all these ...
Tuesday, August 28th 2018
Featured Articles
-
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCIA ...
Since publication of the 2014 joint consensus document dealing with the management of antithrombotic therapy in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or ...
By Lip, Gregory Y H Tuesday, August 14th 2018
-
Live from ESC Congress 2018
Saturday 25 August Time Session 09:00 - 10:30 Expert Advice - Drug prescription in the elderly 10:30 - 11:00 Interlude 11:00 - 12:30 Expert Advice - Diagnosis and treatment of heart failure with ...
Friday, July 27th 2018
-
Hugo A. Katus MD PhD FESCAfter discovering troponin as a biomarker Katus reached out to genome ...
Known for his work developing a cardiac-specific troponin assay that revolutionized the diagnosis and management of myocardial injury, German cardiologist Hugo Katus has in recent years shifted his ...
By Ozkan, Judy Saturday, July 14th 2018
-
Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of ...
Abstract Aims Harmonized Assessment by Randomized Multicentre Study of OrbusNEichs Combo StEnt (HARMONEE) (NCT02073565) was a randomized pivotal registration trial of the Combo stent, which combined ...
By Saito, Shigeru Saturday, July 7th 2018
-
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation ...
Abstract Aims Of patients with atrial fibrillation (AF), approximately 10% undergo percutaneous coronary intervention (PCI). We studied the safety and efficacy of dual vs. triple antithrombotic ...
By Golwala, Harsh B Monday, May 14th 2018
-
âTen Commandmentsâ of the EHRA Guide for the Use of NOACs in AF
Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with atrial fibrillation (AF), and have emerged as the ...
By Steffel, Jan Saturday, April 21st 2018
-
Corrigendum to: Diagnosis and management of acute deep vein thrombosis: a joint consensus document ...
Eur Heart J 2017; DOI: 10.1093/eurheartj/ehx003] ... The authors wish to inform readers that the Conflict of Interest statement was incorrect as first published. The statement should have been ...
Saturday, April 14th 2018
-
Corrigendum to: Diagnosis and management of acute deep vein thrombosis: a joint consensus document ...
Eur Heart J 2017; DOI: 10.1093/eurheartj/ehx003] ... The authors wish to inform readers that the Conflict of Interest statement was incorrect as first published. The statement should have been ...
Saturday, April 14th 2018
-
Corrigendum to: Diagnosis and management of acute deep vein thrombosis: a joint consensus document ...
Eur Heart J 2017; DOI: 10.1093/eurheartj/ehx003] The authors wish to inform readers that the Conflict of Interest statement was incorrect as first published. The statement should have been published ...
Saturday, April 14th 2018
-
Rapidly getting resuscitation skills to the patient with out-of-hospital cardiac arrest
It is well known that any cardio-pulmonary resuscitation (CPR) is better than none and that CPR acts as an effect modifier, increasing the likelihood of patients being found in a salvageable rhythm ...
By Smith, Karen Sunday, April 1st 2018
Hot Topics
- myocardial infarction 10
- atrial fibrillation 9
- heart failure 8
- antiplatelet therapy 6
- acute coronary syndrome 5
- right ventricular function 5
- vein thrombosis 5
- Boehringer Ingelheim 4
- coronary artery disease 4
- joint consensus 4
- percutaneous coronary intervention 4
- personal fees 4
- study population 4
- Bristol-Myers Squibb 3
- Health Care 3
- Supplementary material 3
- anticoagulant therapy 3
- antithrombotic therapy 3
- aortic stenosis 3
- aortic valve 3
- artery disease 3
- bleeding events 3
- cardiovascular disease 3
- dual antiplatelet therapy 3
- european society 3
- inform readers 3
- peripheral circulation 3
- preserved ejection fraction 3
- pulmonary circulation 3
- stent thrombosis 3
Gallery
People
- M.L. Neely 10
- Neville Jackson 10
- P. Clemmensen 10
- P.W. Armstrong 10
- Samantha Goldman 10
- Pierre Fabre 9
- Ann Arbor 8
- Luigi Tavazzi 7
- MJ Price 7
- Marie Curie 7
- Merck Sharpe 7
- Gregg W. 6
- Michel Komajda 6
- David Brieger 5
- G. Montalescot 5
- Hoffmann-La Roche 5
- Richard Gallo 5
- Michael Gibson 4
- Nicolas Danchin 4
- A.A. Badar 3
- Abbott Laboratories 3
- Adriaan Potgieter 3
- Alamo Gels 3
- Alan Kerr 3
- Bernard Charbonnel 3
- Clemens Mittman 3
- Cécile Laroche 3
- David Bilheimer 3
- Edwards Lifesciences 3
- Erin Hanley 3